Osimertinib

Osimertinib (Tagrisso) is a prescription medicine used to treat people with a type of non-small cell lung cancer (NSCLC) that has spread or grown and that tests positive for an abnormal epidermal growth factor receptor (EGFR) gene. It is a type of targeted therapy known as an EGFR tyrosine kinase inhibitor (TKI). Osimertinib works to block the activity of certain proteins that contribute to the growth and spread of cancer cells.

Osimertinib, sold under the brand name Tagrisso, is a medication used for a specific type of lung cancer [1]. Here's a breakdown of its key points:

Intended Use:

• Osimertinib is targeted therapy for epidermal growth factor receptor (EGFR) -mutated non-small cell lung cancer (NSCLC) [1, 2]. NSCLC is the most common type of lung cancer, and EGFR mutations are genetic changes in the EGFR gene found in some lung cancer cases [2, 3].

How it Works:

• Osimertinib belongs to a class of drugs called tyrosine kinase inhibitors (TKIs) [1]. These drugs target specific proteins on the surface of cancer cells, interrupting their growth and spread signals.
• In the case of Osimertinib, it specifically targets mutated EGFR proteins, blocking their ability to promote cancer cell growth and survival [2].

Applications:

• Osimertinib is typically used to treat NSCLC in patients whose tumors have EGFR mutations after initial treatment with another TKI (such as Erlotinib or Gefitinib) [1].
• In some cases, it may also be used as a first-line treatment for EGFR-mutated NSCLC [4].

Considerations:

• Effectiveness: Osimertinib can be effective in shrinking tumors and prolonging survival in patients with EGFR-mutated NSCLC [2].
• Side Effects: Like many medications, Osimertinib can cause side effects. Some common ones include diarrhea, skin rash, dry skin, fatigue, and mouth sores [1].
• Not for Everyone: Osimertinib is not suitable for all NSCLC patients. It's only effective for those with EGFR mutations [2]. Testing is needed to determine if this medication is appropriate for a particular case.
• Resistance: Over time, cancer cells can develop resistance to Osimertinib, rendering it ineffective. This is an ongoing challenge in cancer treatment [5].

Important Note:

• Osimertinib is a prescription medication and should only be taken under the supervision of a doctor. They will determine if it's the right treatment option based on your specific diagnosis and medical history. They can also monitor for side effects and address any concerns you may have.